Chemed (CHE) Expected to Release Quarterly Earnings on Tuesday

Chemed (NYSE:CHE) is projected to release its Q2 2026 results after the market closes on Tuesday, July 28th. Analysts expect the company to post earnings of $5.55 per share and revenue of $665.0360 million for the quarter. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Parties may review the information on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 10:00 AM ET.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same quarter in the prior year, the business posted $5.63 earnings per share. Chemed’s revenue for the quarter was up 1.6% on a year-over-year basis. On average, analysts expect Chemed to post $23 EPS for the current fiscal year and $26 EPS for the next fiscal year.

Chemed Stock Up 0.7%

Shares of CHE opened at $513.83 on Tuesday. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. Chemed has a 12 month low of $365.20 and a 12 month high of $517.74. The stock’s 50 day moving average is $452.22 and its two-hundred day moving average is $431.48. The firm has a market cap of $6.82 billion, a P/E ratio of 28.00, a PEG ratio of 1.88 and a beta of 0.52.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were given a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio (DPR) is 13.08%.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 3.33% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Chemed

A number of hedge funds have recently modified their holdings of CHE. Los Angeles Capital Management LLC purchased a new stake in Chemed in the 4th quarter valued at about $26,000. Global Retirement Partners LLC increased its position in shares of Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after acquiring an additional 58 shares during the last quarter. Geneos Wealth Management Inc. increased its position in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the last quarter. Employees Retirement System of Texas purchased a new stake in shares of Chemed in the 3rd quarter valued at approximately $64,000. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Chemed by 5,333.3% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 163 shares of the company’s stock valued at $73,000 after acquiring an additional 160 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on CHE shares. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Royal Bank Of Canada boosted their price objective on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday. Bank of America raised their price objective on Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Finally, Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Chemed presently has a consensus rating of “Hold” and an average target price of $480.25.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.